CRS Stock Recent News

The future of 3D Printing is supported by its edge over traditional manufacturing and rising adoption. NVDA, GE, CRS and PRLB will likely ride on this trend.

PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, April 24, 2025 at 10:00 a.m. ET to discuss the results of operations for the third quarter of fiscal year 2025, ended March 31, 2025. The call and webcast will follow the release of third quarter fiscal 2025 financial results before the market opens on Thursday, April 24, 2025.

Toronto, Ontario--(Newsfile Corp. - April 3, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX" or "the Company"), a leader in the development of new classes of structured products for the fixed income market, wishes to update investors on the advancements in its Credit Rating Security ("CRS") program. As the merits of the CRS solution becomes more widely recognized, the Company has been able to expand both potential buyers and sellers of CRS to now include three leading hedge funds and two insurance companies, who together are negotiating terms to the first groupings of bonds which will be referenced in these first issuances.

Here is how Carpenter Technology (CRS) and Yara International ASA (YARIY) have performed compared to their sector so far this year.

HOLLYWOOD, Fla., March 21, 2025 (GLOBE NEWSWIRE) -- NV5, a provider of technology, certification, and consulting solutions, announced today that it has completed the acquisition of CRS Survey PLLC (CRS Survey), a provider of land surveying and mapping services for transportation infrastructure and land development to expand and support NV5's existing operation in North Carolina. CRS Survey specializes in conventional and geospatial aerial surveys to support roadway and bridge maintenance and improvements.

Three 3D printing stocks have strong revenues and earnings growth potential for 2025. These are NVDA, GE and CRS.

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10 ‑ million ‑ patient market Acquisition advances Paratek's vision to become a multi-product company focused on innovative specialty therapies Total transaction value of up to ~$330 million Potential consideration of up to $14 per share, including upfront consideration of $9 per share, representing a 50% premium to Optinose's closing trading price on March 19, 2025 BOSTON and YARDLEY, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals and Optinose, Inc. (NASDAQ:OPTN) today announced they have entered into a definitive merger agreement under which Paratek will acquire Optinose, including its approved product XHANCE ® (fluticasone propionate).

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here is how Carpenter Technology (CRS) and Hecla Mining (HL) have performed compared to their sector so far this year.

Carpenter Technology Corporation has strong growth potential in the aerospace & defense and energy markets, driven by high demand for specialty alloys and materials. Improved productivity and pricing have boosted CRS's Specialty Alloys Operations segment margins to 23%. CRS management has guided $500-520mm in operating income for eFY25, with a long-term target of $765-800mm by eFY27, driven by improved pricing and volumes in high-margin markets.